We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+8.11%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.6B
AUM Growth
-$813M
(-6.1%)
Cap. Flow
-$1.34B
Cap. Flow
% of AUM
-10.62%
Top 10 Holdings %
Top 10 Hldgs %
15.55%
Holding
605
New
149
Increased
96
Reduced
113
Closed
185
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$269M |
| 2 |
GE Aerospace
GE
|
+$170M |
| 3 |
Analog Devices
ADI
|
+$142M |
| 4 |
KeyCorp
KEY
|
+$122M |
| 5 |
Motorola Solutions
MSI
|
+$108M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$213M |
| 2 |
GGP
GGP Inc.
GGP
|
+$153M |
| 3 |
General Dynamics
GD
|
+$143M |
| 4 |
Zimmer Biomet
ZBH
|
+$119M |
| 5 |
Equinix
EQIX
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Industrials | 16.34% |
| 3 | Healthcare | 11.75% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Financials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STEL
376
DELISTED
Stellar Bancorp
STEL
| $1.19M | 0.01% |
+40,000
| New | +$1.16M |
|
377
MediWound
MDWD
$184M
| $1.17M | 0.01% |
37,527
-19,616
| -34% | -$660K |
|
378
Benchmark Electronics
BHE
$2.96B
| $1.14M | 0.01% |
+39,159
| New | +$1.22M |
|
379
vTv Therapeutics
VTVT
$136M
| $1.14M | 0.01% |
4,729
-477
| -9% | -$107K |
|
380
Protagonist Therapeutics
PTGX
$9.4B
| $1.04M | 0.01% |
+50,000
| New | +$887K |
|
381
Equifax
EFX
$20.7B
| $1.04M | 0.01% |
8,807
-244,984
| -97% | -$27.5M |
|
|
ACER
382
DELISTED
Acer Therapeutics Inc
ACER
| $1.04M | 0.01% |
+75,000
| New | +$1.22M |
|
|
YOGA
383
DELISTED
YogaWorks, Inc. Common Stock
YOGA
| $991K | 0.01% |
350,000
+48,800
| +16% | +$129K |
|
384
DaVita
DVA
$11.5B
| $967K | 0.01% |
13,386
-28,104
| -68% | -$1.73M |
|
385
Navient
NAVI
$892M
| $924K | 0.01% |
+69,335
| New | +$876K |
|
|
SNNA
386
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
| $924K | 0.01% |
50,909
| – | – |
|
|
AQ
387
DELISTED
Aquantia Corp. Common Stock
AQ
| $909K | 0.01% |
+80,187
| New | +$910K |
|
|
AGRX
388
DELISTED
Agile Therapeutics
AGRX
| $851K | 0.01% |
158
-262
| -62% | -$2.44M |
|
|
EGLT
389
DELISTED
Egalet Corporation
EGLT
| $842K | 0.01% |
842,402
-300,000
| -26% | -$323K |
|
|
SC
390
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $793K | 0.01% |
+42,589
| New | +$713K |
|
391
Teradata
TDC
$2.54B
| $774K | 0.01% |
20,117
-2,744,085
| -99% | -$98.1M |
|
|
MYND
392
Mynd.ai
MYND
$17.4M
| $759K | 0.01% |
4,496
-504
| -10% | -$118K |
|
393
Range Resources
RRC
$9.01B
| $737K | 0.01% |
+43,195
| New | +$777K |
|
|
KDMN
394
CALL
DELISTED
Kadmon Holdings, Inc.
KDMN
| $724K | 0.01% |
200,000
| – | – |
|
|
QEP
395
DELISTED
QEP RESOURCES, INC.
QEP
| $721K | 0.01% |
75,322
-244,868
| -76% | -$2.22M |
|
|
SCMP
396
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $712K | 0.01% |
+39,644
| New | +$488K |
|
397
Xenon Pharmaceuticals
XENE
$6.24B
| $704K | 0.01% |
249,284
-200,000
| -45% | -$544K |
|
|
ALDR
398
DELISTED
Alder Biopharmaceuticals
ALDR
| $703K | 0.01% |
61,414
| – | – |
|
|
FDC
399
DELISTED
First Data Corporation
FDC
| $701K | 0.01% |
41,956
-2,979,149
| -99% | -$51.2M |
|
|
CDTX
400
DELISTED
Cidara Therapeutics
CDTX
| $664K | 0.01% |
4,884
| – | – |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q4 2017 Portfolio in Review
As of Q4 2017, Alyeska Investment Group held 605 positions worth $12.6B, down 6.1% from $13.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Alyeska Investment Group withdrew a net $1.34B in Q4 2017, closing 185 positions and reducing 113 holdings. Its most notable exit was Texas Instruments, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Alyeska Investment Group opened a new position in IBM worth $272M.
- Alyeska Investment Group's largest Q4 2017 buy was IBM: 1,851,994 shares worth $272M.
- Alyeska Investment Group added most to KeyCorp in Q4 2017, an estimated $122M increase.
- Alyeska Investment Group's biggest Q4 2017 reduction was Equinix, cutting an estimated $104M.
- Alyeska Investment Group fully exited Texas Instruments in Q4 2017, selling an estimated $213M.
- Alyeska Investment Group's ten largest holdings make up 16% of its $12.6B portfolio in Q4 2017.
- Alyeska Investment Group opened 149 new positions and closed 185 in Q4 2017.
- Alyeska Investment Group's portfolio value fell 6.1% quarter-over-quarter to $12.6B.
Based on Alyeska Investment Group's 13F filing for Q4 2017, filed 14 Feb 2018.